1. Alkon DL, Amaral DG, Bear MF, Black J, Carew TJ, Cohen NJ, Disterhoft JF, Eichenbaum H, Golski S, Gorman LK et al. (1991): Learning and memory. FESN Study Group Brain Res. Brain Res Reviews 16(2): 193–220.
2. Anderson JP, Refolo LM, Wallace W, Mehta P, Krishnamurthi M, Gotlib J, Bierer L, Haroutunian V, Perl D and Robakis NK (1989): Differential brain expression of the Alzheimer’s amyloid precursor protein. EMBO J 8:3627–3632.
3. Arneric SP, Sullivan JP, Decker MW, Brioni JD, Briggs CA, Donnelly-Roberts D, Marsh KC, Rodrigues AD, Garvey DS, Williams M and Buccafusco JJ (1994): ABT-418: A novel cholinergic channel activator (ChCA) for the potential treatment of Alzheimer disease. In: Alzheimer Disease: Therapeutic Strategies. Giacobini E and Becker R, eds. Boston: Birkhauser, pp. 196–205.
4. Bartus RT, Dean RL, Beer B and Lippa AS (1982): The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417.
5. Beani L, Tanganelli S, Antonelli T and Bianchi C (1986): Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated. J Pharmacol Exp Ther 236: 230–236